HIGHLIGHTS WEBCASTS EARNINGS CONFERENCES SPLITS IPOs ECONOMIC EVENTS DIVIDENDS
ENDO PHARMACEUTICALS HLDGS INC
ENDO PHARMACEUTICALS HLDGS INC Web Site
INVESTOR EVENTS SNAPSHOT PRESS RELEASES FINANCIAL REPORTS REQUEST INFO
       HOME | PROFILE | GOVERNANCE | SHAREHOLDER AND ANALYST INFO Back to Directory   


 

Qualitest Pharmaceuticals Receives FDA Approval for Myzilra(TM) Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.03 mg (28 - Day TriPhasic Regimen)

 
  Message From The Company
This information is not currently provided by ENDO PHARMACEUTICALS HLDGS INC.
  Our Most Recent Webcast
SYMBOL EVENT TITLE  LISTEN DATE TIME (ET)
ENDP Q1 2013 Endo Health Solutions Inc. Earnings Conference Call 7-May-13 8:30 AM
  Our Most Recent Annual Report
SYMBOL REPORT TITLE  DATE FORMAT
ENDP 2010 Annual Report 16-May-2011
 
© 2013 Thomson Reuters. All Rights Reserved.    Terms of Use.   Privacy Statement.
Send questions, comments or suggestions to tfretail@thomson.com.    Earnings dates, Webcast Events, and Conference data provided by Thomson Reuters.